Alpine Associates Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Alpine Associates Management’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,054,475	Closed	-$36.9M	–	60
2024 Q1	$36.9M	Buy	+1,054,475	New	+$38.5M	1.44%	21

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Alpine Associates Management's INBX Position: Q2 2024 in Review

Alpine Associates Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 1,054,475 shares — an estimated $36.9M sold.

Alpine Associates Management first reported a position in INBX in Q1 2024 and held it in 1 quarter. The position peaked at $36.9M in Q1 2024. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Alpine Associates Management reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Alpine Associates Management sold 1,054,475 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $36.9M.
Alpine Associates Management first reported a position in Inhibrx, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Alpine Associates Management's Inhibrx, Inc. Common Stock position peaked at $36.9M in Q1 2024.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Alpine Associates Management's 13F filing for Q2 2024, filed 9 Aug 2024.